The Problem
-
Soluble envelope glycoprotein (Env) trimers are attractive HIV-1 vaccine candidates, but their utility is limited by low stability
-
We used comprehensive mutagenesis to engineer Env trimers to generate variants with increased stability
The Solution
The Impact 
-
We identified 29 Env trimer variants with antigenic improvements
-
The improved trimer variants identified here may be useful to further vaccine discovery